Supplementary Figure 2 from Identification of a Novel Inflamed Tumor Microenvironment Signature as a Predictive Biomarker of Bacillus Calmette-Guérin Immunotherapy in Non–Muscle-Invasive Bladder Cancer

Supplemental Figure 2A shows FGFR3 Expression by UROMOL Subclasses in MSK and UNC cohorts and Supplemental Figure 2B demonstrates the Inverse Relationship between FGFR3 expression and mutation with Immune Signature Score.